COVID-19: Licensing agreement for new candidate drug ‘an important first step’
3 years ago
Access to a new COVID-19 drug will be expanded in low- and middle-income countries following a voluntary licensing agreement between the pharmaceutical company Pfizer and a UN-backed global health initiative, announced in Geneva on Tuesday.
Three Truths to Address Sexual Exploitation, Abuse & Harassment in the UN 
COP27 Fiddling as World Warms 
UN chief highlights crucial role of G20 in resolving global crises 
Somalia: Human rights chief decries steep rise in civilian casualties 
Ukraine: UN convoy delivers vital aid to residents of Kherson 
COP27: Week two opens with focus on water, women and more negotiations on ‘loss and damage’ 
A new treatment could restore some mobility in people paralyzed by strokes 
What has Perseverance found in two years on Mars? 
This robot automatically tucks its limbs to squeeze through spaces 
Greta Thunberg’s new book urges the world to take climate action now